FABBRI, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 54.082
EU - Europa 22.590
AS - Asia 22.480
SA - Sud America 2.409
AF - Africa 421
OC - Oceania 116
Continente sconosciuto - Info sul continente non disponibili 46
Totale 102.144
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 53.456
GB - Regno Unito 8.160
CN - Cina 6.908
SG - Singapore 6.527
IT - Italia 4.560
HK - Hong Kong 2.823
SE - Svezia 1.878
FI - Finlandia 1.856
BR - Brasile 1.855
DE - Germania 1.613
VN - Vietnam 1.595
UA - Ucraina 1.406
BD - Bangladesh 1.165
TR - Turchia 1.071
FR - Francia 800
RU - Federazione Russa 779
KR - Corea 671
BG - Bulgaria 510
IN - India 389
CA - Canada 333
ID - Indonesia 265
NL - Olanda 207
AR - Argentina 192
IQ - Iraq 177
IE - Irlanda 176
MX - Messico 161
JP - Giappone 142
PK - Pakistan 116
ZA - Sudafrica 108
AU - Australia 105
PL - Polonia 92
CO - Colombia 78
AE - Emirati Arabi Uniti 69
BE - Belgio 67
CL - Cile 67
ES - Italia 65
RO - Romania 65
EC - Ecuador 61
AT - Austria 56
MY - Malesia 55
EG - Egitto 54
VE - Venezuela 49
TH - Thailandia 48
PH - Filippine 47
SA - Arabia Saudita 47
MA - Marocco 46
UZ - Uzbekistan 45
CH - Svizzera 43
IR - Iran 39
NP - Nepal 39
TN - Tunisia 38
PY - Paraguay 37
EU - Europa 36
PT - Portogallo 34
JO - Giordania 31
NG - Nigeria 30
TW - Taiwan 28
KE - Kenya 27
PE - Perù 27
UY - Uruguay 26
CR - Costa Rica 25
CZ - Repubblica Ceca 24
AZ - Azerbaigian 23
AL - Albania 22
JM - Giamaica 22
OM - Oman 22
RS - Serbia 21
DZ - Algeria 20
SI - Slovenia 20
BY - Bielorussia 19
DK - Danimarca 18
IL - Israele 18
LT - Lituania 18
BO - Bolivia 16
ET - Etiopia 16
HN - Honduras 15
BH - Bahrain 14
LB - Libano 14
KZ - Kazakistan 13
SY - Repubblica araba siriana 13
AO - Angola 12
KG - Kirghizistan 12
SN - Senegal 12
HR - Croazia 11
DO - Repubblica Dominicana 10
NI - Nicaragua 10
LV - Lettonia 9
PA - Panama 9
TT - Trinidad e Tobago 9
GE - Georgia 8
GT - Guatemala 8
HU - Ungheria 8
MD - Moldavia 8
QA - Qatar 8
BS - Bahamas 7
CI - Costa d'Avorio 7
EE - Estonia 7
GR - Grecia 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
Totale 101.999
Salva come PNG Salva come JPEG
Città #
Southend 6.009
Fairfield 5.795
Ashburn 4.724
Woodbridge 4.243
Singapore 4.183
Santa Clara 3.204
Houston 3.096
Jacksonville 3.095
Hefei 2.808
Hong Kong 2.771
Chandler 2.263
Seattle 2.084
Dearborn 1.993
Wilmington 1.987
Cambridge 1.901
Ann Arbor 1.870
San Jose 1.638
Helsinki 1.353
London 1.294
Beijing 1.079
Nyköping 900
The Dalles 785
Chicago 733
Los Angeles 718
Modena 679
Council Bluffs 673
Seoul 638
San Diego 587
Princeton 556
Milan 532
Izmir 503
Sofia 499
New York 498
Des Moines 496
Eugene 484
Ho Chi Minh City 478
Hanoi 400
Lauterbourg 397
Buffalo 344
Rome 301
Salt Lake City 294
Dallas 239
Moscow 223
Columbus 187
Shanghai 179
Dublin 172
São Paulo 168
Tampa 149
Elk Grove Village 128
Frankfurt am Main 121
Phoenix 119
Jakarta 118
Redwood City 118
Falls Church 116
Palermo 99
Tokyo 99
Guangzhou 97
Norwalk 97
Boardman 92
Naples 92
Da Nang 86
Atlanta 84
Miano 84
Nanjing 84
Kent 83
Grafing 77
Warsaw 75
Sterling 72
Toronto 71
Orem 66
Haiphong 65
Baghdad 64
San Francisco 64
Brooklyn 62
Bari 61
Kunming 61
Lancaster 60
Chennai 56
Falkenstein 56
Amsterdam 55
Verona 54
Mexico City 53
Miami 53
Charlotte 51
Bologna 50
Mumbai 49
Jersey City 47
Jinan 47
Turin 47
Montreal 46
Philadelphia 46
Kilburn 45
Rio de Janeiro 45
Wuhan 45
Boston 44
Brussels 44
Detroit 42
Florence 42
Washington 42
Curitiba 40
Totale 73.816
Salva come PNG Salva come JPEG
Nome #
Medicina Interna Sistematica 2.112
Asma bronchiale 664
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 487
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 486
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary 459
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 453
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 450
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 408
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 404
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 390
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 382
Effects of a walking aid in COPD patients receiving oxygen therapy 376
Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 370
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 361
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 355
Chronic Lung Disease in HIV Patients 346
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 344
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial 340
Role of chemotherapy and the receptor tyrosine kinases KIT, PDGFR alpha, PDGFR beta, and met in large-cell neuroendocrine carcinoma of the lung 337
La broncopneumopatia cronica ostruttiva nell'anziano 332
Treatment of chronic obstructive pulmonary disease and its comorbidities 332
Update in Chronic Obstructive Pulmonary Disease 2005 331
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial 331
Cellular and structural bases of chronic obstructive pulmonary disease 329
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 327
Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma 325
Roflumilast:un nuovo farmaco per il trattamento della BPCO 324
From COPD to chronic systemic inflammatory syndrome? 324
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 323
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 320
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 320
Inhaled Corticosteroids in COPD: Pros and Cons. 317
Update in chronic obstructive pulmonary disease 2006 317
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 317
Complex chronic co-morbidities of COPD 315
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 313
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma 312
Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States 310
Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease 307
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: Two randomised clinical trials 306
Breakthroughs in internal and respiratory medicine 305
Transforming growth factor-β type II receptor in pulmonary arteries of patients with very severe COPD 304
Chronic critical illness: the price of survival 304
Clusterin (CLU) and lung cancer 301
Prognostic role of clusterin in resected adenocarcinomas of the lung. 301
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 300
Insufficienza Respiratoria acuta e cronica (cap.21). 299
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 299
Benralizumab: for asthma, not yet for COPD 296
Early diagnosis of subclinical multi drug-resistant tuberculosis 296
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 296
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 290
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 288
Macrolides in the treatment of asthma and cystic fibrosis 285
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 284
How to Integrate Multiple Comorbidities in Guideline Development 283
Pathophysiology of exacerbations of chronic obstructive pulmonary disease 282
Sarcoidosis: challenging diagnostic aspects of an old disease. 281
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 280
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma. 279
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. 278
Tiotropium versus salmeterol for the prevention of exacerbations of COPD 277
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 277
Mechanisms of bradykinin-induced contraction in human fetal lung fibroblasts. 276
Uniform definition of asthma severity, control, and exacerbations: Document presented for the World Health Organization Consultation on Severe Asthma. 276
Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals. 275
Comparative efficacy of once-daily ciclesonide and budesonide in the treatment of persistent asthma 274
Effect of ADRB2 polymorphisms on the efficacy of salmeterol and tiotropium in preventing COPD exacerbations: a prespecified substudy of the POET-COPD trial 274
COPD and the Solar System:Introducing the Chronic Obstructive Pulmonary Disease Comorbidome 273
Performance of commerical blood tests for the diagnosis of latent tuberculosis infection in children and adolescents 273
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma 272
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 271
Chronic disease in the elderly: back to the future of internal medicine. 270
Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial 270
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials 269
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies 266
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa 266
Asthma in the elderly: what we know and what we have yet to know 266
Efficacy of standard Rehabilitation in COPD Outpatients with Co-morbidities. 265
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 265
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 264
Eosinophilia in asthma: the easy way is not always the best 263
Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate 261
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. 261
Corticosteroid inhibition of airway microvascular leakage. 257
Adjustable maintenance dosing with budesonide/formoterol in a single inhaler provides effective asthma symptom control at a lower dose than fixed maintenance dosing 257
Significant chronic airway abnormalities in never-smoking HIV-infected patients 256
Blood tests for diagnosis of tuberculosis - Reply 255
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial) 255
The distribution of neurokinin-1 and neurokinin-2 receptors in human central airways. 254
Use of a T-cell interferon-γ release assay for the diagnosis of tuberculous pleurisy 254
An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease 252
Phosphodiesterase-4 Inhibitor Therapy for Lung Diseases 252
Effects of early inpatient rehabilitation after acute exacerbation of COPD 251
Effects of unsupported upper extremity exercise training in patients with COPD: A randomized clinical trial 251
The pharmacoepidemiology of COPD: recent advances and methodological discussion. 250
Actions other than smooth muscle relaxation may play a role in the protective effects of formoterol on the allergen-induced late asthmatic reaction. 250
Airway eosinophilia in chronic bronchitis during exacerbations. 250
Mycobacterium tuberculosis induces CCL18 expression in human macrophages 249
Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. 248
Totale 32.632
Salva come PNG Salva come JPEG
Categoria #
all - tutte 399.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 399.226
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228.366 186 1.276 963 673 216 357 636 409 851 561 1.330 908
2022/20236.892 803 496 362 556 845 1.260 116 733 1.035 118 316 252
2023/20244.221 176 311 297 440 772 440 423 530 148 122 143 419
2024/202514.078 611 264 175 868 2.559 1.611 887 778 1.851 905 1.727 1.842
2025/202629.793 1.693 1.357 3.209 2.727 3.304 2.789 4.155 1.475 2.387 2.222 2.488 1.987
2026/202739 39 0 0 0 0 0 0 0 0 0 0 0
Totale 102.615